Maricar Malinis, MD, is an Associate Professor of Medicine in the Division of Infectious Diseases and Medical Director of the Transplant Infectious Diseases Program at Vanderbilt University Medical Center. She is an Associate Professor of Surgery at Vanderbilt University School of Medicine.

She obtained her medical degree at the University of the Philippines College of Medicine. She completed her internal medicine residency at Seton Hall Graduate Medical Education. Afterward, she completed fellowship training in geriatric medicine at the University of Michigan, infectious diseases at the University of Louisville, and transplant infectious diseases at the Cleveland Clinic Foundation. Prior to her appointment in VUMC, she was the medical director of the Transplant Infectious Disease Program and the Director of the Transplant Infectious Disease Clinical Track of the ID fellowship at Yale School of Medicine.

Dr. Malinis is an active member of the American Society of Transplantation (AST), the Transplantation Society, and the Infectious Disease Society of America (IDSA). She had multiple leadership positions in the AST Infectious Diseases Community of Practice, including Chair of the Older Adult Working Group, member at large of the executive committee, and Chair of the HIV working group. She served on various IDSA committees, including the Clinical Affairs Committee (member, 2017-2021), Digital Advisory Group (vice-chair 2020-2021, chair 2021-2023), and IDWeek Program Committee (2019-present). She is the IDSA Immunocompromised Host Community of Practice Chair (2023-2026). She has also served in the UNOS/OPTN as a member of the Ad Hoc Disease Transmission Advisory Committee ( 2017-2020) and a member of the Membership and Professional Standards Committee ( 2023-2025).

Dr. Malinis' commitment to improving patient care is evident in her significant contributions to clinical research. Her research focuses on the clinical outcomes of transplantation in people living with HIV and older adults. She was the primary investigator of the HIV Organ Policy Equity (HOPE) Act clinical trial at Yale and of several multicenter clinical trials of novel antiviral agents for immunocompromised hosts. Her leadership is also evident in her projects on patient safety and quality improvement in care for transplant candidates and recipients, including optimizing vaccination uptake among candidates prior to transplantation.